Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 08 - 2013 Emerging Medical Technologies Report Brochure
Transcript
Brochure More information from http://www.researchandmarkets.com/reports/2671564/ 08 - 2013 Emerging Medical Technologies Report Description: This report includes details on 36 emerging medical technology companies that have been identified by the authors in-house research team in August 2013. All companies include technology, market(s), key executive, and contact information. Coverage includes innovations in a broad spectrum of medical technology areas including: - Aesthetics/Dermatology Companies - Biomaterials Companies - Biotechnology/Cell Therapy Companies - Cardiovascular Companies - Dental Companies - Diagnostics Companies - Drug Delivery Companies - Endocrine Companies - Gastroenterology Companies - Gynecology/Women's Health Companies - Imaging Companies - Neurology Companies - Oncology Companies - Ophthalmology Companies - Orthopedics Companies - Pain Management Companies - Patient Management/Monitoring Companies - Pharmaceutical Companies - Respiratory Companies - Spine Companies - Surgery Companies - Urology Companies - Vascular Companies - Wound Management Companies Contents: BRIEF TECHNOLOGY DESCRIPTIONS FOR COMPANIES COVERED - 1-Easy-to-use, wrist-worn activity monitor that records all movement, not just steps and 2-A social and rewarding group activity program to track daily movement against a group goal - 1-Electro-optic technologies and analytic methods that rapidly detect and quantify bacteria in fluids in realtime and 2-A family of instruments that provide screening for urinary tract infections (UTIs) - 1-Minimally invasive spinal fixation device for spinal fusion as an alternative to pedicle screw fixation; 2Polyether ether ketone interbody cages for use in spinal fusion procedures; and 3-Stand-alone cervical and lumbar systems - 1-Proprietary delayed-release formulation of the most prescribed diabetes medicine in the world, Metformin and 2-Over-the-counter (OTC) products for weight loss and pre-diabetes - Camera-enabled needle technology to fundamentally improve orthopedic diagnostics and therapeutics by enabling instant and accurate office-based procedures - Cryogen-based Global Endometrial Ablation (GEA) technology to quickly and safely achieve tissue ablating temperatures in a single-use, self-contained, hand-held device - Devices for overactive bladder (OAB) - Devices for the treatment of female infertility caused by fallopian tube dysfunction - Dry powder formulations for various therapeutic molecules, including: antibiotics, corticosteroids, nucleic acids, and insoluble and soluble molecules - Ganaxolone, a neurosteroid to treat children and adults suffering from refractory epilepsy, post-traumatic stress disorder (PTSD), and fragile-X syndrome - Immunotherapeutic agents for the treatment of cancer, viral infections, and inflammatory and autoimmune diseases - Implantable meniscus replacement and regeneration device - Implantable technology for direct delivery of therapeutic compounds to the site of brain injury - Implants for unmet needs in the treatment of mitral valve disease, with applications in percutaneous catheter-based intervention and minimally invasive or open-heart cardiac surgery - Intrauterine device (IUD) inserter that vastly simplifies the insertion procedure, while significantly reducing the complications inherent with current insertion techniques for female contraceptives - Microprocessor-based, disposable intravenous (IV) injection port for automated recordkeeping in the perioperative period and the subsequent retrieval and analysis of that data to improve patient safety - Minimally invasive catheter-based system that allows physicians to create an arterio-venous fistula to deliver hemodialysis to patients suffering from kidney failure - New business model for the clinical development and registration of pharmaceutical products, to accelerate the availability of new and innovative drugs into the world's major markets - New drug for treating adrenal cancer - Non-invasive oximeter for the quantitative measurement of cerebral tissue oxygen levels to enable clinicians to identify and quickly react to dangerously low brain oxygen levels, as well as monitor the oxygenation of other tissues, such as muscle and abdominal tissues in newborns - Non-invasive solutions to dramatically improve in vitro fertilization (IVF) outcomes - Non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses - Oral histone deacetylase (HDAC) inhibitor that inhibits cancer-relevant HDAC enzymes, which contribute to epigenetic alterations driving cancer growth and drug tolerance - Oral testosterone (T) replacement product - Pipeline of antibody agents directed to costimulatory targets for the treatment of cancer - Proprietary recombinant polypeptide that, when genetically fused to a therapeutic payload of interest, extends the half-life of proteins and peptides in a tunable manner - Selective and programmable nanomedicines to maximize active pharmaceutical ingredient concentrations in diseased tissues - Small molecule therapeutics to treat multi-drug resistant bacterial infections - Small, cell-permeable RNAi pro-drugs that can enter many different cell types and deliver on the promise of RNAi therapeutics for a wide range of diseases - Synthetic cartilage implant designed to replace or repair worn or damaged cartilage - Technologies that reformulate adult pharmaceuticals for the pediatric market - Technology designed to provide real-time, high-resolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical resection of cancer - Therapies for patients with chronic diseases in nephrology and oncology - Therapies to reverse protein energy wasting in end-stage renal disease - Three-dimensional (3D) cell culture products that mimic the human cellular environment, for drug discovery research and testing, with the potential to replace or reduce the use of animals in pharmaceutical testing - Unique, optimized, high-throughput pharmacology platform that is able to systematically identify new indications for small molecule therapeutics Ordering: Order Online - http://www.researchandmarkets.com/reports/2671564/ Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland. Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit http://www.researchandmarkets.com/contact/ Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: 08 - 2013 Emerging Medical Technologies Report Web Address: http://www.researchandmarkets.com/reports/2671564/ Office Code: SCHL3FA7 Product Formats Please select the product formats and quantity you require: Quantity Electronic (PDF) Single User: USD 199 Electronic (PDF) Enterprisewide: USD 1195 Contact Information Please enter all the information below in BLOCK CAPITALS Title: First Name: Mr Mrs Dr Miss Last Name: Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL) Ms Prof Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an email with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number 833 130 83 Sort code 98-53-30 Swift code ULSBIE2D IBAN number IE78ULSB98533083313083 Bank Address Ulster Bank, 27-35 Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World
